ACE Venture Completes 51% Acquisition of Vireo Health of New York and Launches Boukét
May 5, 2026
ACE Venture, LLC, a New York-based MWBE-certified cannabis holding company, completed its acquisition of a 51% stake in Vireo Health of New York. The deal also supports the launch of Boukét, positioned as New York’s flagship cannabis lifestyle brand, leveraging Vireo’s established medical cannabis license and operating foundation.
- Buyers
- ACE Venture, LLC
- Targets
- Vireo Health of New York
- Sellers
- Vireo Health team, John Mazarakis (mentioned as part of the Vireo team)
- Platforms
- ACE Venture, LLC
- Industry
- Healthcare Services
- Location
- New York, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Vireo Growth Inc. Acquires C21 Investments Inc.
August 21, 2026
Consumer Products
Vireo Growth Inc. completed its acquisition of all outstanding shares of C21 Investments Inc. through a court-approved plan of arrangement, issuing 2,766,409 Vireo shares to C21 shareholders. C21 adds three Nevada dispensaries operating under the Silver State Relief brand and approximately 104,000 square feet of cultivation and production capacity, expanding Vireo’s Nevada operations and creating opportunities for operational synergies.
-
Vireo Growth Completes Acquisition of PharmaCann Colorado Retail Assets
August 7, 2026
Consumer Products
Vireo Growth Inc. has received all required regulatory approvals and completed its previously announced acquisition of certain Colorado retail assets of PharmaCann Inc. Total consideration was approximately $49.0 million, paid via the issuance of Vireo subordinate voting shares and the assumption of certain liabilities.
-
Vireo Growth Inc. Acquires Four Ohio Cannabis Businesses in $208 Million All-Stock Deal
July 31, 2026
Healthcare Services
Vireo Growth Inc. entered into definitive securities purchase agreements to acquire four Ohio entities—FarmaceuticalRx LLC, FarmaceuticalRx 2 LLC, CAOH LLC, and Canoe Hill Ohio, LLC—covering eight dispensaries, a cultivation and processing facility, and related real estate. The aggregate purchase price is expected to be approximately $208 million, paid entirely in Vireo subordinate voting shares in three tranches with deferred performance-based clawbacks. Closing is expected in Q4 2026, subject to regulatory approvals and customary closing conditions.
-
Vireo Growth Inc to Acquire Certain Assets of The Cannabist Company Holdings Inc
July 20, 2026
Healthcare Services
Vireo Growth Inc, through its subsidiary Vireo Health of Arcadia, LLC, entered into a definitive purchase agreement to acquire certain cannabis cultivation, manufacturing, and retail operations from subsidiaries of The Cannabist Company Holdings Inc across Colorado, Illinois, Massachusetts, New Jersey, and West Virginia. The deal consideration is up to US$35 million (subject to regulatory approvals), with closing expected in stages through 2026 and 2027. Vireo expects the transaction to add up to 25 dispensaries and strengthen its vertically integrated presence in multiple limited-license cannabis markets.
-
Vireo Growth Inc. Acquires C21 Investments Inc.
June 15, 2026
Healthcare Services
Vireo Growth Inc. entered into a definitive arrangement agreement to acquire all outstanding common shares of C21 Investments Inc. for stock consideration. The deal is expected to expand Vireo’s Nevada footprint by adding three dispensaries and approximately 104,000 sq. ft. of cultivation and production capacity.
-
Chicago Atlantic and Vireo Growth Agree to Merge and Acquire Cannabis Operators (Including Arches JV and The Flowery)
December 18, 2024
Healthcare Services
Chicago Atlantic (as Vireo’s largest stockholder) and Vireo Growth executed definitive merger agreements to combine with three single-state cannabis operators: Proper Cannabis (Missouri), Deep Roots Harvest (Nevada), and WholesomeCo Cannabis (Utah). The deal also includes an acquisition of the Arches analytics and distribution technology platform joint venture between Wholesome and Proper, and Vireo signed a binding memorandum of understanding to acquire The Flowery (Florida). The combined transactions are valued collectively at about $397 million, subject to customary approvals.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.